Document is current
Any future updates will be listed below
-
Authors
Baker, Kenneth B. http://orcid.org/0000-0002-4435-7015
Plow, Ela B.
Nagel, Sean
Rosenfeldt, Anson B.
Gopalakrishnan, Raghavan
Clark, Cynthia
Wyant, Alexandria
Schroedel, Madeleine
Ozinga, John IV
Davidson, Sara
Hogue, Olivia http://orcid.org/0000-0002-3985-3831
Floden, Darlene http://orcid.org/0000-0002-3131-0058
Chen, Jacqueline
Ford, Paul J. http://orcid.org/0000-0002-5423-8845
Sankary, Lauren
Huang, Xuemei
Cunningham, David A.
DiFilippo, Frank P.
Hu, Bo http://orcid.org/0000-0003-0606-7639
Jones, Stephen E.
Bethoux, Francois
Wolf, Steven L.
Chae, John
Machado, André G. http://orcid.org/0000-0002-8132-5610
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UH3NS100543)
ENSPIRE DBS Therapy, Inc.
- License Information
-
More Information
Article History
Received: 28 November 2022
Accepted: 19 July 2023
First Online: 14 August 2023
Competing interests
: A.G.M. serves as Chief Medical Officer and Chair of the Scientific Advisory Board for Enspire DBS Therapy and is paid with stock options. As the inventor, A.G.M. will receive portions of commercialization and/or Cleveland Clinic Foundation stock revenue and payments through Cleveland Clinic Foundation with fees deducted. B.H. serves as a paid member of the DMC for the corresponding phase I/II study (RESTORE). S.L.W. serves as a member of the Scientific Advisory Board and is a paid consultant to Enspire DBS Therapy. J.C. also serves as a paid consultant, but the agreement is with MetroHealth, and J.C. is their designated representative. J.C. is also a member of the Scientific Advisory Board. K.B. serves on the Scientific Advisory Board and is paid with stock options. In addition, A.B.R. is a paid consultant to Enspire DBS Therapy. Enspire DBS Therapy partially sponsored the study and had access to the safety, feasibility and secondary outcome measures. The company had no role in the drafting or editing of this manuscript.
